Abstract Details
|
Hisatomo Kowa, MD, PhD
(Kobe Univ Graduate School of Health Sciences)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jonathan W. Mink, MD, PhD, FAAN | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
| Takashi Matsukawa, MD | No disclosure on file |
| Shoji Tsuji, MD, PhD (University of Tokyo) | The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd.. |
| Fumio Kanda, MD, PhD, FAAN (Kusunoki Neurology Clinic) | No disclosure on file |
| No disclosure on file |